Efemoral Medical announced long-term results of the first 40 patients treated in the EFEMORAL I first-in-human (FIH) clinical ...

Sonorous Neurovascular, a developer of solutions for cerebral venous diseases and neurovascular interventions, announced that ...

Boston Scientific announced an analysis of 989 patients with hepatocellular carcinoma (HCC) from the PROACTIF prospective real-wo ...

Gore & Associates announced new 12-month findings from the global GORE VIABAHN FORTEGRA Venous Stent IVC trial, which evaluat ...

Gore & Associates announced that its Excluder thoracoabdominal branch endoprosthesis (TAMBE) received CE Mark approval earlie ...

InVera Medical announced 12-month results from its pilot clinical study of the InVera infusion device for the treatment of ...

In this retrospective analysis, Zil-E-Ali et al found that patients with government-funded insurance who underwent urgent or ...

Stryker announced that it has signed a definitive agreement to acquire Amplitude Vascular Systems, Inc. (AVS), which is a private ...

VIRad.AI announced the launch of its artificial intelligence (AI)–powered clinical decision support platform, designed spec ...

RenovoRx, Inc., which is developing targeted oncology therapies and commercializing its FDA-cleared RenovoCath drug-delivery devi ...

The results from the OCEANIC-STROKE study were published by Mukul Sharma, MD, et al in The New England Journal of Medicine (NEJM; ...

Cook Medical and Siemens Healthineers introduced their integrated interventional MRI (iMRI) suite at SIR 2026, the Society of ...